Regeneron (REGN) Target Raised to $375 at Deutsche Bank

November 5, 2013 1:05 PM

Deutsche Bank maintained a Buy rating on Regeneron Pharma (NASDAQ: REGN) and raised its price target to $375.00 (from $310.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found